Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study
Authors:
- Nienke LegdeurNLNienke Legdeur
- Maryam BadissiMBMaryam Badissi
- Stephen F. CarterSCStephen F. Carter
- Sophie de CromSCSophie de Crom
- Aleid van de KreekeAKAleid van de Kreeke
- Ralph VreeswijkRVRalph Vreeswijk
- Marijke C. TrappenburgMTMarijke C. Trappenburg
- Mardien L. OudegaMOMardien L. Oudega
- Huiberdina L. KoekHuiberdina L. Koek
- Jos P. van CampenJCJos P. van Campen
- Carolina J. P. W. KeijsersCKCarolina J. P. W. Keijsers
- Chinenye AmadiCAChinenye Amadi
Open Access
- 26 November 2018
- journal article
- research article
- Published by Springer Nature in BMC Geriatrics
- Vol. 18 (1) , 289
Abstract
The oldest-old (subjects aged 90 years and older) population represents the fastest growing segment of society and shows a high dementia prevalence rate of up to 40%. Only a few studies have investigated protective factors for cognitive impairment in the oldest-old. The EMIF-AD 90+ Study aims to identify factors associated with resilience to cognitive impairment in the oldest-old. In this paper we reviewed previous studies on cognitive resilience in the oldest-old and described the design of the EMIF-AD 90+ Study. The EMIF-AD 90+ Study aimed to enroll 80 cognitively normal subjects and 40 subjects with cognitive impairment aged 90 years or older. Cognitive impairment was operationalized as amnestic mild cognitive impairment (aMCI), or possible or probable Alzheimer’s Disease (AD). The study was part of the European Medical Information Framework for AD (EMIF-AD) and was conducted at the Amsterdam University Medical Centers (UMC) and at the University of Manchester. We will test whether cognitive resilience is associated with cognitive reserve, vascular comorbidities, mood, sleep, sensory system capacity, physical performance and capacity, genetic risk factors, hallmarks of ageing, and markers of neurodegeneration. Markers of neurodegeneration included an amyloid positron emission tomography, amyloid β and tau in cerebrospinal fluid/blood and neurophysiological measures. The EMIF-AD 90+ Study will extend our knowledge on resilience to cognitive impairment in the oldest-old by extensive phenotyping of the subjects and the measurement of a wide range of potential protective factors, hallmarks of aging and markers of neurodegeneration. Nederlands Trial Register NTR5867 . Registered 20 May 2016.Keywords
Funding Information
- EU/EFPIA Innovative Medicines Initiative Joint Undertaking (115372)
- NIHR UCLH Biomedical Research Centre
This publication has 130 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Frequency-dependent functional connectivity within resting-state networks: An atlas-based MEG beamformer solutionNeuroImage, 2012
- Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohortSleep Medicine, 2011
- Genetic variations in the CLU and PICALM genes are associated with cognitive function in the oldest oldNeurobiology of Aging, 2011
- Pro12Ala polymorphism in PPAR-γ2 and dementia in Chinese nonagenarians/centenariansAGE, 2010
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- The Mn-superoxide dismutase single nucleotide polymorphism rs4880 and the glutathione peroxidase 1 single nucleotide polymorphism rs1050450 are associated with aging and longevity in the oldest oldMechanisms of Ageing and Development, 2009
- The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screeningInternational Journal of Geriatric Psychiatry, 2006
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1982
- Studies of Illness in the AgedJAMA, 1963